Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced vasculitis.

P A Merkel1

  • 1Arthritis Center, Boston University School of Medicine, and Rheumatology Section, Boston University Medical Center, Boston, Massachusetts, USA. pmerkel@bu.edu

Rheumatic Diseases Clinics of North America
|November 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A disease-associated gene desert directs macrophage inflammation through ETS2.

Nature·2024
Same author

Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study.

Scandinavian journal of rheumatology·2018
Same author

Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Clinical and experimental immunology·2017
Same author

Clinicians' perspective on key domains in ANCA-associated vasculitis: a Delphi exercise.

Scandinavian journal of rheumatology·2016
Same author

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.

Annals of the rheumatic diseases·2016
Same author

Pulmonary function tests, interstitial lung disease and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis.

The British journal of dermatology·2016

Drug-induced vasculitis (DIV) is a common inflammatory condition. Diagnosis involves excluding other causes, and treatment focuses on drug withdrawal, with immunosuppressants used for severe cases.

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Background:

  • Drug-induced vasculitis (DIV) is a recognized cause of inflammatory vasculitis.
  • Numerous drug classes are implicated, with varying evidence quality.
  • Clinical presentation ranges from skin involvement to severe multi-organ disease.

Purpose of the Study:

  • To review the landscape of drug-induced vasculitis.
  • To highlight diagnostic and therapeutic considerations.
  • To discuss emerging subsets like ANCA-associated DIV.

Main Methods:

  • Literature review of drug-induced vasculitis.
  • Analysis of clinical manifestations and diagnostic challenges.
  • Evaluation of treatment strategies.

Related Experiment Videos

Main Results:

  • DIV presents with diverse clinical features, often skin-limited but can be systemic.
  • Diagnosis is typically made by exclusion.
  • Withdrawal of the offending drug is the cornerstone of treatment.

Conclusions:

  • DIV requires careful diagnosis, often by exclusion.
  • Treatment is guided by severity, prioritizing drug cessation.
  • Further understanding of pathophysiology may improve management.